Vasoactive intestinal peptide and pituitary adenylate cyclase activating polypeptide stimulate interleukin-6 production in prostate cancer cells and prostatic epithelial cells.

May 5, 2005Oncology reports

Two peptides increase inflammation-related protein production in prostate and prostate cancer cells

AI simplified

Abstract

VIP stimulated the production of interleukin-6 (IL-6) in DU-145/AR prostate cancer and normal prostate epithelial cells.

  • VPAC1, VPAC2, and PAC1 receptor mRNAs were present in both prostate cancer cells and normal prostate epithelial cells.
  • PACAP also increased IL-6 production in normal prostate epithelial cells.
  • VIP enhanced IL-6 promoter transcriptional activity specifically in DU-145/AR prostate cancer cells.
  • VIP and PACAP may influence IL-6 production in normal and cancerous prostate cells.

AI simplified

what lands in your inbox each week:

  • 📚7 fresh studies
  • 📝plain-language summaries
  • direct links to original studies
  • 🏅top journal indicators
  • 📅weekly delivery
  • 🧘‍♂️always free